Hormone Sensitive Prostate Cancer: Clinical Trials

3 trials for Hormone Sensitive Prostate Cancer, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 completed, 1 unknown. 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 13Active not recruiting 1, Completed 1, Unknown 1

Follow Hormone Sensitive Prostate Cancer: new trials by email Literature Review of Hormone Sensitive Prostate Cancer trials Research Report on Hormone Sensitive Prostate Cancer

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
[Ac-225]-PSMA-62 Trial in Oligometastatic Hormone Sensitive and Metastatic Castration Resistant Prostate Cancer
[Ac-225]-PSMA-62 (mCRPC), [Ac-225]-PSMA-62 (OmHSPC) - Prostate Cancer, Metastatic Castration-resistant Prostate Cancer
Phase 1Active not recruitingEli Lilly and Company1422024-04-032026-10-06
Effect of Low-dose 500 mg Abiraterone Acetate in Treatment of Metastatic Prostate Cancer Patients
Abiraterone Acetate - Prostate Cancer, Metastatic Cancer
Phase 1UnknownNational University Hospital, Singapore102021-11-302024-01-08
A Phase 1 Dose Escalation and Expansion Study Of SHR7280 In Subjects With Hormone Sensitive Prostate Cancer
SHR7280 - Hormone Sensitive Prostate Cancer
Phase 1CompletedJiangsu HengRui Medicine Co., Ltd.122021-09-242023-09-21

Narrower conditions

Prostatic Neoplasms (2)  ·  Genital Neoplasms, Male (1)  ·  Neoplasm Metastasis (1)  ·  Urogenital Neoplasms (1)

Broader conditions

Genital Diseases (2)  ·  Genital Diseases, Male (2)  ·  Male Urogenital Diseases (2)  ·  Neoplasms (2)  ·  Neoplasms by Site (2)  ·  Prostatic Diseases (2)  ·  Urogenital Diseases (2)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Genital Neoplasms, Male (1)  ·  Neoplastic Processes (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Urogenital Neoplasms (1)

Interventions

Abiraterone Acetate (1)

Sponsors

Eli Lilly and Company (1)  ·  Jiangsu HengRui Medicine Co., Ltd. (1)  ·  National University Hospital, Singapore (1)

Countries

Canada (1)  ·  China (1)  ·  Singapore (1)

Top investigators

Edmund Chiong, MBBS, PhD (1)